9th July, 2025 🔍 Introduction In a significant move toward the digitization of drug regulatory processes in India, the Central Drugs Standard Control Organization (CDSCO), in collaboration with the Centre for Development of Advanced Computing (CDAC), has introduced a major…
May 1, 2020 Central Drugs Standard Control Organization (CDSCO), the Government of India Drug Regulatory Agency has extended the validity of WHO GMP/ Certificate of Pharmaceutical Product (COPP) expiring from March 2020 to August 2020 by six months from…
Recent Post
- When a “+” Sign Isn’t Just a Plus
- DCC intends to tighten control on manufacturing and supply of printed packaging materials used for drugs
- High-Alcohol Oral Formulations Move Into Schedule H1
- DCC Recommends Comprehensive Regulatory Mechanism to Curb Unapproved Drugs and FDCs
- DCC Recommends Mandatory Public Disclosure of Suspended and Cancelled Drug Licenses
